Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Tuma

Showing results (61-70 of 102) with videos related to

Pageof 11
Sort By:
Journal of the National Cancer Institute|August 10, 2007
Peering past exhibitor displays at meetingsRabiya S Tuma
Journal of the National Cancer Institute|May 6, 2004
A big trial for a new technology: TransBIG Project takes microarrays into clinical trialsRabiya S Tuma
Journal of the National Cancer Institute|March 3, 2005
Multiple gene signatures aim to qualify risk in breast cancerRabiya S Tuma
Journal of the National Cancer Institute|September 2, 2004
Three molecularly targeted drugs tested in kidney cancer clinical trialsRabiya S Tuma
Journal of the National Cancer Institute|September 11, 2008
New response criteria proposed for immunotherapiesRabiya S Tuma
Journal of the National Cancer Institute|January 30, 2009
Agents targeting apoptosis show promise in early trialsRabiya S Tuma
Journal of the National Cancer Institute|September 27, 2007
Unusual comparison between trials uncovers key genetic polymorphismsRabiya S Tuma
Journal of the National Cancer Institute|July 7, 2005
Success of bevacizumab trials raises questions for future studiesRabiya S Tuma
Journal of the National Cancer Institute|August 18, 2005
Efforts aimed at reducing noise, data overload in microarraysRabiya S Tuma
Journal of the National Cancer Institute|March 8, 2007
Lapatinib moves forward in inflammatory and early HER2-positive breast cancer trialsRabiya S Tuma
Pageof 11

Showing results (61-70 of 102) with videos related to

Sort By:
Pageof 11
Journal of the National Cancer Institute|August 10, 2007
Peering past exhibitor displays at meetingsRabiya S Tuma
Journal of the National Cancer Institute|May 6, 2004
A big trial for a new technology: TransBIG Project takes microarrays into clinical trialsRabiya S Tuma
Journal of the National Cancer Institute|March 3, 2005
Multiple gene signatures aim to qualify risk in breast cancerRabiya S Tuma
Journal of the National Cancer Institute|September 2, 2004
Three molecularly targeted drugs tested in kidney cancer clinical trialsRabiya S Tuma
Journal of the National Cancer Institute|September 11, 2008
New response criteria proposed for immunotherapiesRabiya S Tuma
Journal of the National Cancer Institute|January 30, 2009
Agents targeting apoptosis show promise in early trialsRabiya S Tuma
Journal of the National Cancer Institute|September 27, 2007
Unusual comparison between trials uncovers key genetic polymorphismsRabiya S Tuma
Journal of the National Cancer Institute|July 7, 2005
Success of bevacizumab trials raises questions for future studiesRabiya S Tuma
Journal of the National Cancer Institute|August 18, 2005
Efforts aimed at reducing noise, data overload in microarraysRabiya S Tuma
Journal of the National Cancer Institute|March 8, 2007
Lapatinib moves forward in inflammatory and early HER2-positive breast cancer trialsRabiya S Tuma
Pageof 11